160 related articles for article (PubMed ID: 35854304)
1. Assessment of the association of OCT3/4 with GLUT1 and CD105 in oral squamous cell carcinoma using dual immunohistochemistry.
Derakhshan S; Mahdavi N; Kardouni Khoozestani N; Nasr Esfahani B; Heidarian F; Rahrotaban S; Abdolrahmani A
BMC Oral Health; 2022 Jul; 22(1):300. PubMed ID: 35854304
[TBL] [Abstract][Full Text] [Related]
2. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
3. Microvascular density and tumor budding in oral squamous cell carcinoma.
Assis EM; Rodrigues M; Vieira JC; Pascoaloti MI; Júnior HM; Souto GR; Souza PE; Horta MC
Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e174-e182. PubMed ID: 36565216
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunohistochemical expression of vascular endothelial growth factor and CD105 in oral squamous cell carcinoma: Its correlation with prognosis.
Patil BR; Bhat K; Somannavar P; Hosmani J; Kotrashetti V; Nayak R
J Cancer Res Ther; 2018; 14(2):421-427. PubMed ID: 29516931
[TBL] [Abstract][Full Text] [Related]
7. Ki-67, CD105, and α-smooth muscle actin expression in oral squamous cell carcinoma corresponds with different forms of tobacco consumption habits.
Gadbail AR; Sarode SC; Chaudhary MS; Gondivkar SM; Tekade SA; Yuwanati M; Sarode GS; Hande A; Patil S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S197-S204. PubMed ID: 36510964
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20.
Chen CH; Chuang HC; Lin YT; Fang FM; Huang CC; Chen CM; Lu H; Chien CY
Tumour Biol; 2016 Feb; 37(2):1995-2005. PubMed ID: 26334621
[TBL] [Abstract][Full Text] [Related]
9. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.
Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM
J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
[TBL] [Abstract][Full Text] [Related]
11. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
[TBL] [Abstract][Full Text] [Related]
12. Novel fluorescent GLUT1 inhibitor for precision detection and fluorescence image-guided surgery in oral squamous cell carcinoma.
Tian Y; Tang C; Shi G; Wang G; Du Y; Tian J; Zhang H
Int J Cancer; 2022 Aug; 151(3):450-462. PubMed ID: 35478458
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma.
Escobar E; Gómez-Valenzuela F; Peñafiel C; Hormazábal-Hevia A; Herrera-Fuentes C; Mori-Aliaga D
Rev Esp Patol; 2023; 56(3):147-157. PubMed ID: 37419553
[TBL] [Abstract][Full Text] [Related]
14. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
15. VEGF expression and angiogenesis in oral squamous cell carcinoma: an immunohistochemical and morphometric study.
Mărgăritescu C; Pirici D; Stîngă A; Simionescu C; Raica M; Mogoantă L; Stepan A; Ribatti D
Clin Exp Med; 2010 Dec; 10(4):209-14. PubMed ID: 20376688
[TBL] [Abstract][Full Text] [Related]
16. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
Tandon A; Singh NN; Gulati N
Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
18. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
19. m
Cui Y; Liu J; Liu L; Ma X; Gui Y; Liu H; Zhao W
Cancer Gene Ther; 2023 Jan; 30(1):163-171. PubMed ID: 36127411
[TBL] [Abstract][Full Text] [Related]
20. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
